3rd Symposium

7 May 2010

Practical focus on the diagnosis and treatment of the psychiatric and neuropsychological aspects of HIV-infected patients.

Milton Wainberg, M.D.

Columbia University. New York, USA

Depresion and other neuropsychiatric disorders. (risk factors, prevention, diagnosis and treatment).

Saye H. Koo, M.D.

Department of Pharmacology at the University of Liverpool. United Kingdom.

Clinically significant interactions between neuropsychiatric and antiretroviral drugs and pharmacokinetic.

Scott Letendre, M.D.

University of California. San Diego, USA

Neurocognitive impairment (risk factors, prevention, diagnosis and treatment).

Andrea Antinori, M.D.

Clinical Department. National Institute for Infectious Diseases. L. Spallanzani, IRCCS. Rome, Italy.

Presentation of clinical cases

Jose A. Muñoz-Moreno, Ph.D.

Lluita contra les Infeccions Foundation, Germans Trias i Pujol University Hospital. Barcelona, Spain

Workshop. Developing skills on neuropsychological screening in clinical practice: which tools, which patients and when monitoring.